• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CRITICAL CARE AB FLOW-I; GAS-MACHINE, ANESTHESIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CRITICAL CARE AB FLOW-I; GAS-MACHINE, ANESTHESIA Back to Search Results
Model Number FLOW-I C20
Device Problems Contamination /Decontamination Problem (2895); Output Problem (3005)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/25/2021
Event Type  malfunction  
Event Description
It was reported that the sevoflurane vaporizer had a yellow residue on the inside.The vaporizer is the unit containing anesthetic agent in the anesthesia workstation.There was no patient harm.Manufacturer's reference #: (b)(4).
 
Manufacturer Narrative
The vaporizers with yellow residue has been shown to contain hydrogen fluoride by chemical analysis during the ongoing investigation.The anesthetic agent sevoflurane is susceptible to various types of chemical degradation.This report is a result of the confirmation of the presence of hydrogen fluoride and has prompted a review of complaints and the returned vaporizers for the past 2 years.
 
Event Description
Manufacturer's reference #: (b)(4).
 
Manufacturer Narrative
The investigation has been completed.The vaporizer was returned for investigation and the reported issue was confirmed.The yellow residue inside the vaporizer has been analyzed in a chemical analyze and the cause of the yellow residue is due to degradation of sevoflurane creating hydrogen fluoride.The concerned vaporizers are sevoflurane with maquet fill and safe-t-seal (which is keyed to sevoflurane from baxter).A root cause analysis has been performed regarding the formation of hydrogen fluoride within sevoflurane vaporizers.The root cause analysis found that changes in design and manufacturing process introduced in 2018 was the reason for the formation of hydrogen fluoride.The main reason for the manufacturing change in 2018 was to facilitate easier assembling in production and to get a better sourcing of certain components.The surface treatment in the aluminum canister that form the main part of the liquid container in the vaporizer was found to be inadequate.To prevent this from happening the sevoflurane vaporizer will be redesigned.The fsca has been initiated to remove all the concerned vaporizers from the field.The removing of the concerned vaporizers are to be completed until (b)(6) 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLOW-I
Type of Device
GAS-MACHINE, ANESTHESIA
Manufacturer (Section D)
MAQUET CRITICAL CARE AB
roentgenvagen 2
solna
Manufacturer (Section G)
MAQUET CRITICAL CARE AB
roentgenvagen 2
solna
Manufacturer Contact
sara soderholm roman
roentgenvagen 2
solna 
MDR Report Key12836352
MDR Text Key280962484
Report Number8010042-2021-02731
Device Sequence Number1
Product Code BSZ
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
K191027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 11/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/18/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFLOW-I C20
Device Catalogue Number6677200
Was Device Available for Evaluation? Yes
Date Manufacturer Received07/15/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2019
Is the Device Single Use? No
Type of Device Usage Unknown
Removal/Correction NumberZ-0468-2022
Patient Sequence Number1
-
-